BELZUTIFAN for Neoplasm: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 10 adverse event reports in the FDA FAERS database where BELZUTIFAN was used for Neoplasm.
Most Reported Side Effects for BELZUTIFAN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Anaemia | 154 | 15.1% | 8 | 72 |
| Fatigue | 88 | 8.6% | 0 | 16 |
| Hypoxia | 85 | 8.3% | 7 | 65 |
| Diarrhoea | 42 | 4.1% | 0 | 27 |
| Death | 41 | 4.0% | 38 | 2 |
| Dyspnoea | 40 | 3.9% | 0 | 26 |
| Haemoglobin decreased | 36 | 3.5% | 0 | 6 |
| Malignant neoplasm progression | 36 | 3.5% | 10 | 11 |
| Off label use | 35 | 3.4% | 2 | 2 |
| Oxygen saturation decreased | 30 | 2.9% | 0 | 14 |
| Nausea | 28 | 2.7% | 0 | 14 |
| Product dose omission issue | 25 | 2.5% | 0 | 3 |
| Therapy interrupted | 25 | 2.5% | 0 | 11 |
| Pneumonia | 24 | 2.4% | 3 | 22 |
| No adverse event | 22 | 2.2% | 0 | 0 |
Other Indications for BELZUTIFAN
Renal cell carcinoma (291)
Clear cell renal cell carcinoma (237)
Renal cancer (186)
Von hippel-lindau disease (55)
Haemangioblastoma (28)
Phakomatosis (17)
Product used for unknown indication (12)
Endometrial adenocarcinoma (11)
Hepatocellular carcinoma (7)
Adenocarcinoma pancreas (5)
Other Drugs Used for Neoplasm
BEVACIZUMAB (502)
ATEZOLIZUMAB (404)
CYCLOPHOSPHAMIDE (385)
CARBOPLATIN (283)
PACLITAXEL (267)
NIVOLUMAB (219)
OXALIPLATIN (185)
PEMBROLIZUMAB (173)
LENALIDOMIDE (171)
DOXORUBICIN (150)